LEHNES PHARMACOLOGY FOR NURSING CARE 10TH EDITION BURCHUM TEST BANK
TEST BANK
Pharmacology and the Nursing Process
9th Edition
Linda Lane Lilley, Shelly Rainforth Collins, Julie S. Snyder
NURSINGTB.COM
NURSINGTB.COM
, LEHNES PHARMACOLOGY FOR NURSING CARE 10TH EDITION BURCHUM TEST BANK
Contents
Chapter 01: The Nursing Process and Drug Therapy ..................................................................................... 4
Chapter 02: Pharmacologic Principles ........................................................................................................... 8
Chapter 03: Lifespan Considerations ........................................................................................................... 14
Chapter 04: Cultural, Legal, and Ethical Considerations .............................................................................. 20
Chapter 05: Medication Errors: Preventing and Responding ...................................................................... 26
Chapter 06: Patient Education and Drug Therapy ....................................................................................... 29
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements .............................................. 34
Chapter 08: Gene Therapy and Pharmacogenomics ................................................................................... 38
Chapter 09: Photo Atlas of Drug Administration ......................................................................................... 41
Chapter 10: Analgesic Drugs........................................................................................................................ 50
Chapter 11: General and Local Anesthetics................................................................................................. 57
Chapter 12: Central Nervous System Depressants and Muscle Relaxants .................................................. 61
Chapter 13: Central Nervous System Stimulants and Related Drugs .......................................................... 66
Chapter 14: Antiepileptic Drugs .................................................................................................................. 70
Chapter 15: Antiparkinson D r u g s . . . . . . . . . . . . . . . . . .N. .U. . .R. . S. .I. N
. . .G. . .T. .B. . ..C. . .O. . M............................................ 76
Chapter 16: Psychotherapeutic Drugs ......................................................................................................... 81
Chapter 17: Substance Use Disorder ........................................................................................................... 88
Chapter 18: Adrenergic Drugs ..................................................................................................................... 93
Chapter 19: Adrenergic-Blocking Drugs ...................................................................................................... 98
Chapter 20: Cholinergic Drugs ................................................................................................................... 103
Chapter 21: Cholinergic-Blocking Drugs .................................................................................................... 108
Chapter 22: Antihypertensive Drugs ......................................................................................................... 113
Chapter 23: Antianginal Drugs .................................................................................................................. 119
Chapter 24: Heart Failure Drugs ................................................................................................................ 125
Chapter 25: Antidysrhythmic Drugs .......................................................................................................... 131
Chapter 26: Coagulation Modifier Drugs................................................................................................... 137
Chapter 27: Antilipemic Drugs................................................................................................................... 143
Chapter 28: Diuretic Drugs ........................................................................................................................ 148
Chapter 29: Fluids and Electrolytes ........................................................................................................... 154
Chapter 30: Pituitary Drugs ....................................................................................................................... 160
NURSINGTB.COM
, LEHNES PHARMACOLOGY FOR NURSING CARE 10TH EDITION BURCHUM TEST BANK
rt rt rt rt rt rt rt rt rt
Chapter 31: Thyroid and Antithyroid Drugs .............................................................................................. 163
Chapter 32: Antidiabetic Drugs ................................................................................................................. 168
Chapter 33: Adrenal Drugs ........................................................................................................................ 177
Chapter 34: Women’s Health Drugs .......................................................................................................... 181
Chapter 35: Men’s Health Drugs ............................................................................................................... 188
Chapter 36: Antihistamines, Decongestants, Antitussives, and Expectorants .......................................... 193
Chapter 37: Respiratory Drugs .................................................................................................................. 198
Chapter 38: Antibiotics Part 1 ................................................................................................................... 204
Chapter 39: Antibiotics Part 2 ................................................................................................................... 211
Chapter 40: Antiviral Drugs ....................................................................................................................... 216
Chapter 41: Antitubercular Drugs ............................................................................................................. 221
Chapter 42: Antifungal Drugs .................................................................................................................... 226
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs ............................................................ 231
Chapter 44: Anti-inflammatory and Antigout Drugs ................................................................................. 236
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs ...................... 242
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugs and Miscellaneous Drugs .......... 248
NURSINGTB.COM
Chapter 47: Biologic Response–Modifying and Antirheumatic Drugs ....................................................... 253
Chapter 48: Immunosuppressant Drugs.................................................................................................... 258
Chapter 49: Immunizing Drugs .................................................................................................................. 263
Chapter 50: Acid-Controlling Drugs ........................................................................................................... 268
Chapter 51: Bowel Disorder Drugs ............................................................................................................ 274
Chapter 52: Antiemetic and Antinausea Drugs ......................................................................................... 281
Chapter 53: Vitamins and Minerals ........................................................................................................... 286
Chapter 54: Anemia Drugs......................................................................................................................... 292
Chapter 55: Nutritional Supplements........................................................................................................ 299
Chapter 56: Dermatologic Drugs ............................................................................................................... 304
Chapter 57: Ophthalmic Drugs .................................................................................................................. 310
Chapter 58: Otic Drugs .............................................................................................................................. 315
NURSINGTB.COM
, LEHNES PHARMACOLOGY FOR NURSING CARE 10TH EDITION BURCHUM TEST BANK
rt rt rt rt rt rt rt rt rt
Chapter 01: The Nursing Process and Drug Therapy rt rt rt rt rt rt rt r t r t 4
Chapter 01: The Nursing Process and Drug Therapy rt rt rt rt rt rt rt
MULTIPLE CHOICE rt
1. The nurse is writing a nursing diagnosis for a plan of care for a patient who has been newly diag
rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt
nosed with type 2 diabetes. Which statement reflects the correct format for a nursing diagnosis
rt rt rt rt rt rt rt rt rt rt rt rt rt rt
?
a. Anxiety
b. Anxiety related to new drug therapy rt rt rt rt rt
c. Anxiety related to anxious feelings about drug therapy, as evidenced by statements rt rt rt rt rt rt rt rt rt rt rt
such as “I’m upset about having to test my blood sugars.”
rt rt rt rt rt rt rt rt rt rt
d. Anxiety related to new drug therapy, as evidenced by statements such as “I’m rt rt rt rt rt rt rt rt rt rt rt rt
upset about having to test my blood sugars.” rt rt rt rt rt rt rt
ANS: D r t
Formulation of nursing diagnoses is usually a three-step process. “Anxiety” is missing the rt rt rt rt rt rt rt rt rt rt rt rt
“related to” and “as evidenced by” portions of defining characteristics. “Anxiety related to new drug
rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt
therapy” is missing the “as evidenced by” portion of defining characteristics. The statement beginnin
rt rt rt rt rt rt rt rt rt rt rt rt rt
g “Anxiety related to anxious feelings” is incorrect because the “related to” section is
rt rt rt rt rt rt rt rt rt rt rt rt rt
simply a restatement of the problem “anxiety,” not a separate factor related to the response.
rt rt rt rt rt rt rt rt rt rt rt rt rt rt
DIF:
COGNITIVE LEVEL: Understanding(Comprehension) rt rt rt rt
TOP: NURSING PROCESS: Nursing DiagNnUosRiSs INGTB.COM
r t rt rt rt
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
r t rt rt rt rt rt rt rt rt
2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was busy and gav
rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt
e the medication 2 hours after the scheduled dose was due. What type of problem does this represen
rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt
t?
a. “Right time” rt
b. “Right dose” rt
c. “Right route” rt
d. “Right medication” rt
ANS: A r t
“Right time” is correct because the medication was given more than 30 minutes after the
rt rt rt rt rt rt rt rt rt rt rt rt rt rt
scheduled dose was due. “Dose” is incorrect because the dose is not related to the time the
rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt
medication administration is scheduled. “Route” is incorrect because the route is not affected. “Medicati
rt rt rt rt rt rt rt rt rt rt rt rt rt
on” is incorrect because the medication ordered will not change.
rt rt rt rt rt rt rt rt rt
DIF:
COGNITIVE LEVEL: Applying (Application) rt rt rt rt
TOP: NURSING PROCESS: Implementation
r t rt rt
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
r t rt rt rt rt rt rt rt rt rt
3. The nurse has been monitoring the patient’s progress on a new drug regimen since the first dose and
rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt
documenting the patient’s therapeutic response to the medication. Which phase of the nursing proc rt rt rt rt rt rt rt rt rt rt rt rt rt
ess do these actions illustrate?
rt rt rt rt
a. Nursing diagnosis rt
NURSINGTB.COM
TEST BANK
Pharmacology and the Nursing Process
9th Edition
Linda Lane Lilley, Shelly Rainforth Collins, Julie S. Snyder
NURSINGTB.COM
NURSINGTB.COM
, LEHNES PHARMACOLOGY FOR NURSING CARE 10TH EDITION BURCHUM TEST BANK
Contents
Chapter 01: The Nursing Process and Drug Therapy ..................................................................................... 4
Chapter 02: Pharmacologic Principles ........................................................................................................... 8
Chapter 03: Lifespan Considerations ........................................................................................................... 14
Chapter 04: Cultural, Legal, and Ethical Considerations .............................................................................. 20
Chapter 05: Medication Errors: Preventing and Responding ...................................................................... 26
Chapter 06: Patient Education and Drug Therapy ....................................................................................... 29
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements .............................................. 34
Chapter 08: Gene Therapy and Pharmacogenomics ................................................................................... 38
Chapter 09: Photo Atlas of Drug Administration ......................................................................................... 41
Chapter 10: Analgesic Drugs........................................................................................................................ 50
Chapter 11: General and Local Anesthetics................................................................................................. 57
Chapter 12: Central Nervous System Depressants and Muscle Relaxants .................................................. 61
Chapter 13: Central Nervous System Stimulants and Related Drugs .......................................................... 66
Chapter 14: Antiepileptic Drugs .................................................................................................................. 70
Chapter 15: Antiparkinson D r u g s . . . . . . . . . . . . . . . . . .N. .U. . .R. . S. .I. N
. . .G. . .T. .B. . ..C. . .O. . M............................................ 76
Chapter 16: Psychotherapeutic Drugs ......................................................................................................... 81
Chapter 17: Substance Use Disorder ........................................................................................................... 88
Chapter 18: Adrenergic Drugs ..................................................................................................................... 93
Chapter 19: Adrenergic-Blocking Drugs ...................................................................................................... 98
Chapter 20: Cholinergic Drugs ................................................................................................................... 103
Chapter 21: Cholinergic-Blocking Drugs .................................................................................................... 108
Chapter 22: Antihypertensive Drugs ......................................................................................................... 113
Chapter 23: Antianginal Drugs .................................................................................................................. 119
Chapter 24: Heart Failure Drugs ................................................................................................................ 125
Chapter 25: Antidysrhythmic Drugs .......................................................................................................... 131
Chapter 26: Coagulation Modifier Drugs................................................................................................... 137
Chapter 27: Antilipemic Drugs................................................................................................................... 143
Chapter 28: Diuretic Drugs ........................................................................................................................ 148
Chapter 29: Fluids and Electrolytes ........................................................................................................... 154
Chapter 30: Pituitary Drugs ....................................................................................................................... 160
NURSINGTB.COM
, LEHNES PHARMACOLOGY FOR NURSING CARE 10TH EDITION BURCHUM TEST BANK
rt rt rt rt rt rt rt rt rt
Chapter 31: Thyroid and Antithyroid Drugs .............................................................................................. 163
Chapter 32: Antidiabetic Drugs ................................................................................................................. 168
Chapter 33: Adrenal Drugs ........................................................................................................................ 177
Chapter 34: Women’s Health Drugs .......................................................................................................... 181
Chapter 35: Men’s Health Drugs ............................................................................................................... 188
Chapter 36: Antihistamines, Decongestants, Antitussives, and Expectorants .......................................... 193
Chapter 37: Respiratory Drugs .................................................................................................................. 198
Chapter 38: Antibiotics Part 1 ................................................................................................................... 204
Chapter 39: Antibiotics Part 2 ................................................................................................................... 211
Chapter 40: Antiviral Drugs ....................................................................................................................... 216
Chapter 41: Antitubercular Drugs ............................................................................................................. 221
Chapter 42: Antifungal Drugs .................................................................................................................... 226
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs ............................................................ 231
Chapter 44: Anti-inflammatory and Antigout Drugs ................................................................................. 236
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs ...................... 242
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugs and Miscellaneous Drugs .......... 248
NURSINGTB.COM
Chapter 47: Biologic Response–Modifying and Antirheumatic Drugs ....................................................... 253
Chapter 48: Immunosuppressant Drugs.................................................................................................... 258
Chapter 49: Immunizing Drugs .................................................................................................................. 263
Chapter 50: Acid-Controlling Drugs ........................................................................................................... 268
Chapter 51: Bowel Disorder Drugs ............................................................................................................ 274
Chapter 52: Antiemetic and Antinausea Drugs ......................................................................................... 281
Chapter 53: Vitamins and Minerals ........................................................................................................... 286
Chapter 54: Anemia Drugs......................................................................................................................... 292
Chapter 55: Nutritional Supplements........................................................................................................ 299
Chapter 56: Dermatologic Drugs ............................................................................................................... 304
Chapter 57: Ophthalmic Drugs .................................................................................................................. 310
Chapter 58: Otic Drugs .............................................................................................................................. 315
NURSINGTB.COM
, LEHNES PHARMACOLOGY FOR NURSING CARE 10TH EDITION BURCHUM TEST BANK
rt rt rt rt rt rt rt rt rt
Chapter 01: The Nursing Process and Drug Therapy rt rt rt rt rt rt rt r t r t 4
Chapter 01: The Nursing Process and Drug Therapy rt rt rt rt rt rt rt
MULTIPLE CHOICE rt
1. The nurse is writing a nursing diagnosis for a plan of care for a patient who has been newly diag
rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt
nosed with type 2 diabetes. Which statement reflects the correct format for a nursing diagnosis
rt rt rt rt rt rt rt rt rt rt rt rt rt rt
?
a. Anxiety
b. Anxiety related to new drug therapy rt rt rt rt rt
c. Anxiety related to anxious feelings about drug therapy, as evidenced by statements rt rt rt rt rt rt rt rt rt rt rt
such as “I’m upset about having to test my blood sugars.”
rt rt rt rt rt rt rt rt rt rt
d. Anxiety related to new drug therapy, as evidenced by statements such as “I’m rt rt rt rt rt rt rt rt rt rt rt rt
upset about having to test my blood sugars.” rt rt rt rt rt rt rt
ANS: D r t
Formulation of nursing diagnoses is usually a three-step process. “Anxiety” is missing the rt rt rt rt rt rt rt rt rt rt rt rt
“related to” and “as evidenced by” portions of defining characteristics. “Anxiety related to new drug
rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt
therapy” is missing the “as evidenced by” portion of defining characteristics. The statement beginnin
rt rt rt rt rt rt rt rt rt rt rt rt rt
g “Anxiety related to anxious feelings” is incorrect because the “related to” section is
rt rt rt rt rt rt rt rt rt rt rt rt rt
simply a restatement of the problem “anxiety,” not a separate factor related to the response.
rt rt rt rt rt rt rt rt rt rt rt rt rt rt
DIF:
COGNITIVE LEVEL: Understanding(Comprehension) rt rt rt rt
TOP: NURSING PROCESS: Nursing DiagNnUosRiSs INGTB.COM
r t rt rt rt
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
r t rt rt rt rt rt rt rt rt
2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was busy and gav
rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt
e the medication 2 hours after the scheduled dose was due. What type of problem does this represen
rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt
t?
a. “Right time” rt
b. “Right dose” rt
c. “Right route” rt
d. “Right medication” rt
ANS: A r t
“Right time” is correct because the medication was given more than 30 minutes after the
rt rt rt rt rt rt rt rt rt rt rt rt rt rt
scheduled dose was due. “Dose” is incorrect because the dose is not related to the time the
rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt
medication administration is scheduled. “Route” is incorrect because the route is not affected. “Medicati
rt rt rt rt rt rt rt rt rt rt rt rt rt
on” is incorrect because the medication ordered will not change.
rt rt rt rt rt rt rt rt rt
DIF:
COGNITIVE LEVEL: Applying (Application) rt rt rt rt
TOP: NURSING PROCESS: Implementation
r t rt rt
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
r t rt rt rt rt rt rt rt rt rt
3. The nurse has been monitoring the patient’s progress on a new drug regimen since the first dose and
rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt rt
documenting the patient’s therapeutic response to the medication. Which phase of the nursing proc rt rt rt rt rt rt rt rt rt rt rt rt rt
ess do these actions illustrate?
rt rt rt rt
a. Nursing diagnosis rt
NURSINGTB.COM
